click below
click below
Normal Size Small Size show me how
Ph Neuro Parkinson
Pharma Neuro
Question | Answer |
---|---|
Drug induced parkinsonism | Neuroleptics/Antipsychotics; Prochlorperazine; Metoclopramide; Valproate; Amiodarone; Phenytoin; Lithium |
Levodopa does not improve: | postural instability, dementia, autonomic dysfunction or freezing |
Begin levodopa tx when: | pt experiences functional impairment |
Levodopa CI | Hypersensitivity, narrow angle glaucoma, melanoma or undiagnosed skin lesions |
Levodopa biggest AE | N&V; give 30 min before/60 min after meal, but can give w/meal, decrease GI sx; avoid high pro diet (competes w/pro to cross BBB) |
Levodopa AE (all) | N/V; postural hypotension; cardiac arrhythmia; mental disturbance; dyskinesias (TD; on-off fx or wearing-off fx: shorten interval); psychomotor excitation (agitation, hypomanic) |
Levodopa DI | MAOI (hypertensive rxn); Antipsychotics (decrease L-dopa fx); Fe salts (dec absorpn of L-dopa); Metoclopramide, phenytoin (dec fx of L-dopa) |
Levodopa CR | no difference in off-time |
DA agonists: MOA | Act directly on dopamine receptors in the corpus striatum (Mirapex: renal elim/dose adj; Requip: C450) |
DA agonists: ergot derivatives: AE | retroperitoneal, pleural & pericardial fibrosis; Cardiac valve fibrosis |
DA agonists: AE | Dizziness; HA; insomnia; somnolence; confusion; hallucinations; Dry mouth, nausea; constipation; ortho hypoTN; syncope; Dyskinesias; impulse control disorders (compulsive gambling/binge eating) |
DA: DI | CYP3A4 inhib (protease inhibs, antifungal, macrolides); antipsychotic (dec fx of DA); Efavirenz (ischemia); Metoclopramide (dec DA fx); Serotonin modulators (serotonin syndrome) |
Rescue therapy for Off episodes: | Apomorphine; titration & test dose under medical supervision (risk of ortho hypoTN) |
Apomorphine AE | Yawning; Dyskinesia; N/V; Dizziness; Angina; Rhinorrhea; Hallucinations, impulse control disorders, melanoma, orthostasis |
Apomorphine DI | Cipro (QT prolong); Serotonin antagonists (enhance hypoTN); Antipyschotics, Prochlorperazine, Metoclopramide (diminish fx) |
COMT inhib MOA | Increase amount of levodopa available to cross BBB (allows prolonged On periods; often add on when levodopa efficacy begins to diminish) |
COMT inhib DI | MAOI; EtOH |
Tolcapone monitoring | LFTs baseline, then every 2-4 weeks for 6 months, then periodically |
COMT inhib AE | Liver failure (tolcapone); inc levodopa exposure; Dyskinesias; N/V; Dizziness; Hallucinations; Urine discoloration; Abd pain; Diarrhea; Orthostasis; Somnolence; HA |
Comtan AE | urine brownish-orange |
Selegiline MOA | Acts centrally to prevent DA destruction (MAO-B: metab of DA); fx diminish over time |
MAO-B DI | Sympathomimetics (HTN fx; avoid); Meperidine, Dextromethorphan, SSRI (serotonin syn); MAOI orthostasis; Ciprofloxacin (sd inc rasagiline conc) |
MAO-B CI | mirtazapine |
MAO-B AE | Not hypertensive (MAOI) rxn; insomnia; N/V |
Rasagiline AE | HA; dizziness; N/V; Dyskinesias & orthostasis (combo w/ levodopa) |
Anticholinergics: indication in Parkinsons | Reserved for resting tremor early in the dz in younger pts |
Antiviral agent that may be used alone or in combo w/ levodopa = | Amantadine (Symmetrel) |
Amantadine fx | tachyphylaxis dev w/in 3 mos (req higher & higher doses) (withdraw, d/c & reintroduce); reduces dyskinesias (used late in dz) |
Amantadine MOA | augment DA presynaptic release; block reuptake; block glutamate transmission; renal metab (dose adj) |
Amantadine AE | convulsion (at higher doses); ankle edema; livedo reticularis; plus the usual sx |
Amantadine DI | antipsychotics; EtOH |
Parkinson: other poss tx | antioxidants (vit E Not Recommended); Coenzyme Q10 (no proven fx); creatine/minocycline (?) |